BIOMAT Database Logo BIOMAT Database Logo

Immunoreactivity of T-cells from leprosy patients to ICRC and M. leprae antigens before and after vaccination. 1990

S G Gangal, and S V Chiplunkar, and S R Shinde, and P D Samson, and M G Deo
Cancer Research Institute, Tata Memorial Centre, Parel, Bombay.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D009166 Mycobacterium leprae A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D015440 Leprosy, Lepromatous A chronic communicable infection which is a principal or polar form of LEPROSY. This disorder is caused by MYCOBACTERIUM LEPRAE and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage. Leprosy, Cutaneous,Leprosy, Nodular,Cutaneous Leprosies,Cutaneous Leprosy,Lepromatous Leprosies,Lepromatous Leprosy,Leprosies, Cutaneous,Leprosies, Lepromatous,Leprosies, Nodular,Nodular Leprosies,Nodular Leprosy

Related Publications

S G Gangal, and S V Chiplunkar, and S R Shinde, and P D Samson, and M G Deo
Ability of M. leprae, Mycobacterium w, and ICRC bacillus to produce macrophage activating factors from lymphocytes of leprosy patients.
October 1978, Leprosy in India,
S G Gangal, and S V Chiplunkar, and S R Shinde, and P D Samson, and M G Deo
Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
October 1977, Leprosy in India,
S G Gangal, and S V Chiplunkar, and S R Shinde, and P D Samson, and M G Deo
Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
September 1995, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
S G Gangal, and S V Chiplunkar, and S R Shinde, and P D Samson, and M G Deo
A systematic molecular analysis of the T cell-stimulating antigens from Mycobacterium leprae with T cell clones of leprosy patients. Identification of a novel M. leprae HSP 70 fragment by M. leprae-specific T cells.
November 1991, Journal of immunology (Baltimore, Md. : 1950),
S G Gangal, and S V Chiplunkar, and S R Shinde, and P D Samson, and M G Deo
Antigens of Mycobacterium leprae and anti-M. leprae antibodies in the urine of leprosy patients.
September 1983, Leprosy review,
S G Gangal, and S V Chiplunkar, and S R Shinde, and P D Samson, and M G Deo
Lymphoproliferative responses of leprosy patients and healthy controls to nitrocellulose-bound M. leprae antigens.
June 1999, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
S G Gangal, and S V Chiplunkar, and S R Shinde, and P D Samson, and M G Deo
Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
March 1996, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
S G Gangal, and S V Chiplunkar, and S R Shinde, and P D Samson, and M G Deo
Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to antigens from cultivable saprophytic mycobacteria.
October 1978, Leprosy in India,
S G Gangal, and S V Chiplunkar, and S R Shinde, and P D Samson, and M G Deo
Reactions to antigens from actinomycetes including Mycobacterium leprae in leprosy patients.
June 1991, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
S G Gangal, and S V Chiplunkar, and S R Shinde, and P D Samson, and M G Deo
In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients.
April 1983, Clinical and experimental immunology,
Copied contents to your clipboard!